L’Oreal (LRLCY) announced the acquisition of an additional 10% in Galderma Group AG (GALDY) from a consortium led by EQT, which includes Sunshine SwissCo GmbH, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd. for an undisclosed amount. The transaction brings L’Oreal ownership of Galderma’s share capital to 20%. In connection with the increased investment, the board of Directors of Galderma will consider nominating two non-independent board candidates from L’Oreal, replacing the consortium led by EQT, as from the 2026 Annual General Meeting. L’Oreal said it will continue to support the company’s strategy and independence under the leadership of Flemming Ornskov, M.D., MPH, CEO of Galderma, and is not contemplating to increase its stake.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRLCY:
- Cautious Outlook for L’Oreal Amid Competitive Pressures and Valuation Concerns
- Cautious Outlook on L’Oreal: Concerns Over Luxe Division’s Growth and Strategy Shift
- L’Oreal upgraded to Buy from Neutral at Rothschild & Co Redburn
- Citi places ‘upside 90-day catalyst watch’ on L’Oreal
- Midday Fly By: Berkshire takes Alphabet stake, J&J buying cancer drug maker